Japan Tobacco, Inc. Share Price BOERSE MUENCHEN

Equities

JAT

JP3726800000

Tobacco

Market Closed - BOERSE MUENCHEN 01:14:13 29/06/2024 am IST 5-day change 1st Jan Change
25.18 EUR -0.98% Intraday chart for Japan Tobacco, Inc. 0.00% +12.74%

Financials

Sales 2024 * 3,017B 18.74B 17.5B 1,562B Sales 2025 * 3,122B 19.4B 18.11B 1,617B Capitalization 7,719B 47.96B 44.77B 3,998B
Net income 2024 * 500B 3.1B 2.9B 259B Net income 2025 * 532B 3.31B 3.09B 276B EV / Sales 2024 * 2.51 x
Net cash position 2024 * 139B 865M 808M 72.11B Net cash position 2025 * 249B 1.55B 1.44B 129B EV / Sales 2025 * 2.39 x
P/E ratio 2024 *
15.4 x
P/E ratio 2025 *
14.5 x
Employees -
Yield 2024 *
4.68%
Yield 2025 *
5%
Free-Float 53.82%
More Fundamentals * Assessed data
Dynamic Chart
1 week-3.19%
Current month-3.86%
1 month-2.18%
3 months+1.78%
6 months+9.24%
Current year+8.72%
More quotes
1 week
25.00
Extreme 25
26.49
1 month
25.00
Extreme 25
27.24
3 years
15.14
Extreme 15.135
27.24
5 years
14.65
Extreme 14.65
27.24
10 years
14.65
Extreme 14.65
38.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 01/89/01
Director of Finance/CFO - 01/23/01
Chairman 63 01/03/01
Members of the board TitleAgeSince
Director/Board Member 63 01/19/01
Director/Board Member 70 01/22/01
Chairman 63 01/03/01
More insiders
Date Price Change
28/24/28 25.18 -0.98%
27/24/27 25.43 -2.60%
26/24/26 26.11 -0.34%
25/24/25 26.2 +0.81%
24/24/24 25.99 -0.08%

Real-time BOERSE MUENCHEN, June 29, 2024 at 01:14 am IST

More quotes
Japan Tobacco Inc. specializes in manufacturing and marketing of tobacco products. The group's products include primarily cigarettes, cigars, chewing and snuff tobaccos. Net sales break down by activity as follows: - sale of tobacco products overseas (66%): 460 billion products sold in 2021, under the brands Winston, Camel, Silk Cut, Sobranie, Glamour, etc.; - sale of tobacco products in Japan (24.1%): 67 billion products sold under the brands Cabin Prestige, Seven Stars, Pianissimo, Mild Seven, etc.; - distribution of food products (6.3%); - development of pharmaceutical products (3.5%): primarily for dyslipidemia, osteoporosis and Hepatitis C treatment; - other (0.1%). 68.5% of net sales are abroad.
Sector
Tobacco
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
4,348 JPY
Average target price
4,383 JPY
Spread / Average Target
+0.80%
Consensus